Ambrx Biopharma Cayman, Inc. Income Statement | Understand Stock

Login

Understand Stock

Sign in or create a free account to unlock 10 years of data, build your watchlist, create alerts and more.

Sign in

$11.33 +$1.08 (10.54%)

Deep Research with AI Research

Overview

Overview Financials SEC Filings Executives News

Specialized Tools

Valuations P Insider Transactions P Congressional Trades P

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Income Statement

Concept	2022	2021	2020	2019
Revenue	$7.402M -0.71% YoY	$7.455M -45.47% YoY	$13.67M 32.59% YoY	$10.31M N/A
Cost Of Revenue	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A
Selling, General & Admin	$42.90M 134.75% YoY	$18.27M 140.57% YoY	$7.596M -0.6% YoY	$7.642M N/A
Research & Development	$53.31M -0.56% YoY	$53.61M 179.34% YoY	$19.19M -23.67% YoY	$25.14M N/A
Depreciation & Amortization	$800.0K -62.86% YoY	$2.154M 10.86% YoY	$1.943M -5.36% YoY	$2.053M N/A
Operating Expenses	$83.80M 16.59% YoY	$71.88M 168.35% YoY	$26.79M -18.29% YoY	$32.78M N/A
Operating Profit	-$76.40M 18.59% YoY	-$64.42M N/A	N/A	N/A
Interest Expense	$968.0K -124.8% YoY	-$3.903M -14555.56% YoY	$27.00K -86.15% YoY	$195.0K N/A
Other Income/Expense, Net	$342.0K 755.0% YoY	$40.00K -100.84% YoY	-$4.750M 12400.0% YoY	-$38.00K N/A
Pretax Income	-$76.06M 11.38% YoY	-$68.29M 282.82% YoY	-$17.84M -20.06% YoY	-$22.32M N/A
Income Tax	$1.937M 193600.0% YoY	$1.000K 0.0% YoY	$1.000K -150.0% YoY	-$2.000K N/A
Net Earnings	-$78.00M 14.57% YoY	-$68.08M 311.53% YoY	-$16.54M -17.54% YoY	-$20.06M N/A
Basic Earnings Per Share	-$0.29 -39.58% YoY	-$0.48 N/A	N/A	N/A
Diluted Earnings Per Share	-$0.29 -100.0% YoY	-$252.0K 301.72% YoY	-$62.74K -17.54% YoY	-$76.08K N/A
COMMON SHARES	N/A	N/A	N/A	N/A
Basic Shares Outstanding	270.2M 88.75% YoY	143.2M N/A	N/A	N/A
Diluted Shares Outstanding	270.2M 88.75% YoY	143.2M N/A	N/A	N/A

Concept	2023 Q2	2023 Q1	2022 Q4	2022 Q2	2021 Q4	2021 Q2
Revenue	$1.123M -61.44% YoY	$24.00K -98.51% YoY	$4.490M 93.28% YoY	$2.912M -43.26% YoY	$2.323M N/A	$5.132M -20.8% YoY
Cost Of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Admin	$6.450M -38.61% YoY	$6.857M N/A	$13.64M 55.05% YoY	$10.51M 10.83% YoY	$8.795M N/A	$9.479M 221.0% YoY
Research & Development	$14.39M -54.53% YoY	$9.750M -33.69% YoY	$18.35M -43.81% YoY	$31.65M 51.05% YoY	$32.65M N/A	$20.96M 118.92% YoY
Depreciation & Amortization	$200.0K -81.85% YoY	$365.0K N/A	$701.0K -40.24% YoY	$1.102M 21940.0% YoY	$1.173M N/A	$5.000K -99.49% YoY
Operating Expenses	$20.29M -51.87% YoY	$16.06M -26.14% YoY	$31.98M -22.83% YoY	$42.16M 38.53% YoY	$41.45M N/A	$30.43M 142.99% YoY
Operating Profit	-$19.17M -33.39% YoY	-$16.03M -20.34% YoY	N/A	-$28.78M N/A	N/A	N/A
Interest Expense	$1.639M -320.89% YoY	$741.0K N/A	$1.111M N/A	-$742.0K -80.99% YoY	$0.00 N/A	-$3.903M -11927.27% YoY
Other Income/Expense, Net	$1.649M -1429.84% YoY	$803.0K -185.97% YoY	$97.00K 83.02% YoY	-$124.0K 853.85% YoY	$53.00K N/A	-$13.00K -50.0% YoY
Pretax Income	-$17.52M -64.8% YoY	-$15.23M -27.69% YoY	-$26.29M -32.72% YoY	-$49.77M 70.35% YoY	-$39.07M N/A	-$29.22M 383.9% YoY
Income Tax	$305.0K -82.23% YoY	$73.00K -95.4% YoY	$221.0K N/A	$1.716M 171500.0% YoY	$0.00 N/A	$1.000K 0.0% YoY
Net Earnings	-$17.83M -65.38% YoY	-$15.30M -32.43% YoY	-$26.51M -32.15% YoY	-$51.49M 77.49% YoY	-$39.07M N/A	-$29.01M 433.76% YoY
Basic Earnings Per Share	-$0.05 -54.55% YoY	-$0.05 -37.5% YoY	N/A	-$0.11 N/A	N/A	N/A
Diluted Earnings Per Share	-$0.05 -100.0% YoY	-$0.05 -37.5% YoY	-$0.10 -100.0% YoY	-$190.5K 60.65% YoY	-$132.2K N/A	-$118.6K 475.21% YoY
COMMON SHARES	N/A	N/A	N/A	N/A	N/A	N/A
Basic Shares Outstanding	386.6M 43.1% YoY	386.5M 43.08% YoY	N/A	270.2M N/A	N/A	N/A
Diluted Shares Outstanding	391.3M 44.83% YoY	315.0M 16.6% YoY	N/A	270.2M N/A	N/A	N/A

Loading...